Interleukin-17 stimulates STAT3-mediated endothelial cell activation for neutrophil recruitment

Cellular Physiology and Biochemistry

Volumn 36, Issue 6, 2015, Pages 2340-2356

  Yuan, Shaopeng ^a   Zhang, Shimeng ^b   Zhuang, Yuanyuan ^a   Zhang, He ^b   Bai, Jinye ^a   Hou, Qi ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Chemokine; Endothelial cells activation; Interleukin 17; Neutrophil recruitment; Signal transducers and activators of transcription 3

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 8; SMALL INTERFERING RNA; STAT3 PROTEIN; IL17A PROTEIN, HUMAN; PHOSPHOTYROSINE;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; HL 60 CELL LINE; INFLAMMATION; METABOLISM; MICROVASCULATURE; PATHOLOGY; PHOSPHORYLATION;

CELLS, CULTURED; ENDOTHELIAL CELLS; HL-60 CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-17; MICROVESSELS; NEUTROPHIL INFILTRATION; NEUTROPHILS; PHOSPHORYLATION; PHOSPHOTYROSINE; STAT3 TRANSCRIPTION FACTOR;

EID: 84939610107     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430197     Document Type: Article

References (55)

1. Korn T, Bettelli E, Oukka M, Kuchroo VK: Il-17 and th17 cells. Annu Rev Immunol 2009;27:485-517.
2. Gu C, Wu L, Li X: Il-17 family: Cytokines, receptors and signaling. Cytokine 2013;64:477-485.
3. Park SJ, Lee YC: Interleukin-17 regulation: An attractive therapeutic approach for asthma. Respir Res 2010;11:78.
4. Torrado E, Cooper AM: Il-17 and th17 cells in tuberculosis. Cytokine Growth Factor Rev 2010;21:455-462.
5. Alcorn JF, Crowe CR, Kolls JK: Th17 cells in asthma and copd. Annu Rev Physiol 2010;72:495-516.
6. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT: Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003;101:2620-2627.
7. Roussel L, Houle F, Chan C, Yao Y, Berube J, Olivenstein R, Martin JG, Huot J, Hamid Q, Ferri L, Rousseau S: Il-17 promotes p38 mapk-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010;184:4531-4537.
8. Gaffen SL: Recent advances in the il-17 cytokine family. Curr Opin Immunol 2011;23:613-619.
9. Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato F, Romagnani S, Cassatella MA: Evidence for a cross-talk between human neutrophils and th17 cells. Blood 2010;115:335-343.
10. Chung AS, Wu X, Zhuang G, Ngu H, Kasman I, Zhang J, Vernes JM, Jiang Z, Meng YG, Peale FV, Ouyang W, Ferrara N: An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med 2013;19:1114-1123.
11. Linden A, Laan M, Anderson GP: Neutrophils, interleukin-17a and lung disease. Eur Respir J 2005;25:159-172.
12. Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, Kanamoto M, Nishihara M, Iwakura Y, Hirano T: Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 2008;29:628-636.
13. Brackett CM, Muhitch JB, Evans SS, Gollnick SO: Il-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation. J Immunol 2013;191:4348-4357.
14. Hosokawa Y, Hosokawa I, Ozaki K, Nakanishi T, Nakae H, Matsuo T: Catechins inhibit ccl20 production in il-17a-stimulated human gingival fibroblasts. Cell Physiol Biochem 2009;24:391-396.
15. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A: Neutrophil function: From mechanisms to disease. Annu Rev Immunol 2012;30:459-489.
16. Walters EH, Reid D, Soltani A, Ward C: Angiogenesis: A potentially critical part of remodelling in chronic airway diseases? Pharmacol Ther 2008;118:128-137.
17. Bailey SR, Boustany S, Burgess JK, Hirst SJ, Sharma HS, Simcock DE, Suravaram PR, Weckmann M: Airway vascular reactivity and vascularisation in human chronic airway disease. Pulm Pharmacol Ther 2009;22:417-425.
18. Karbach S, Croxford AL, Oelze M, Schuler R, Minwegen D, Wegner J, Koukes L, Yogev N, Nikolaev A, Reissig S, Ullmann A, Knorr M, Waldner M, Neurath MF, Li H, Wu Z, Brochhausen C, Scheller J, Rose-John S, Piotrowski C, Bechmann I, Radsak M, Wild P, Daiber A, von Stebut E, Wenzel P, Waisman A, Munzel T: Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol 2014;34:2658-2668.
19. Honorati MC, Neri S, Cattini L, Facchini A: Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage 2006;14:345-352.
20. Chauhan SK, Jin Y, Goyal S, Lee HS, Fuchsluger TA, Lee HK, Dana R: A novel pro-lymphangiogenic function for th17/il-17. Blood 2011;118:4630-4634.
21. Moran EM, Connolly M, Gao W, McCormick J, Fearon U, Veale DJ: Interleukin-17a induction of angiogenesis, cell migration, and cytoskeletal rearrangement. Arthritis Rheum 2011;63:3263-3273.
22. Chen Y, Zhong M, Liang L, Gu F, Peng H: Interleukin-17 induces angiogenesis in human choroidal endothelial cells in vitro. Invest Ophthalmol Vis Sci 2014;55:6968-6975.
23. Tsai HC, Velichko S, Hung LY, Wu R: Il-17a and th17 cells in lung inflammation: An update on the role of th17 cell differentiation and il-17r signaling in host defense against infection. Clin Dev Immunol 2013;2013:267971.
24. Chang SH, Dong C: Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell Signal 2011;23:1069-1075.
25. Chen J, Liao MY, Gao XL, Zhong Q, Tang TT, Yu X, Liao YH, Cheng X: Il-17a induces pro-inflammatory cytokines production in macrophages via mapkinases, nf-kappab and ap-1. Cell Physiol Biochem 2013;32:1265-1274.
26. May MJ: Il-17r signaling: New players get in on the act1. Nat Immunol 2011;12:813-815.
27. Huang F, Kao CY, Wachi S, Thai P, Ryu J, Wu R: Requirement for both jak-mediated pi3k signaling and act1/ traf6/tak1-dependent nf-kappab activation by il-17a in enhancing cytokine expression in human airway epithelial cells. J Immunol 2007;179:6504-6513.
28. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R: Stimulation of airway mucin gene expression by interleukin (il)-17 through il-6 paracrine/autocrine loop. J Biol Chem 2003;278:17036-17043.
29. Gao H, Ward PA: Stat3 and suppressor of cytokine signaling 3: Potential targets in lung inflammatory responses. Expert Opin Ther Targets 2007;11:869-880.
30. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C: Stat3 regulates cytokinemediated generation of inflammatory helper t cells. J Biol Chem 2007;282:9358-9363.
31. Benekli M, Baer MR, Baumann H, Wetzler M: Signal transducer and activator of transcription proteins in leukemias. Blood 2003;101:2940-2954.
32. Yeh M, Gharavi NM, Choi J, Hsieh X, Reed E, Mouillesseaux KP, Cole AL, Reddy ST, Berliner JA: Oxidized phospholipids increase interleukin 8 (il-8) synthesis by activation of the c-src/signal transducers and activators of transcription (stat)3 pathway. J Biol Chem 2004;279:30175-30181.
33. Yahata Y, Shirakata Y, Tokumaru S, Yamasaki K, Sayama K, Hanakawa Y, Detmar M, Hashimoto K: Nuclear translocation of phosphorylated stat3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J Biol Chem 2003;278:40026-40031.
34. Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S, Li PK, Li C, Fuchs J, Lin J: Novel stat3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Res 2010;70:2445-2454.
35. Yuan S, Fu Y, Wang X, Shi H, Huang Y, Song X, Li L, Song N, Luo Y: Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis. Faseb J 2008;22:2809-2820.
36. Zha X, Hu Z, He S, Wang F, Shen H, Zhang H: Tsc1/tsc2 inactivation inhibits akt through mtorc1-dependent up-regulation of stat3-pten cascade. Cancer Lett 2011;313:211-217.
37. Guo Y, Liao Y, Jia C, Ren J, Wang J, Li T: Microrna-182 promotes tumor cell growth by targeting transcription elongation factor a-like 7 in endometrial carcinoma. Cell Physiol Biochem 2013;32:581-590.
38. Jiang HL, Xu D, Yu H, Ma X, Lin GF, Ma DY, Jin JZ: Dax-1 inhibits hepatocellular carcinoma proliferation by inhibiting beta-catenin transcriptional activity. Cell Physiol Biochem 2014;34:734-742.
39. Hauert AB, Martinelli S, Marone C, Niggli V: Differentiated hl-60 cells are a valid model system for the analysis of human neutrophil migration and chemotaxis. Int J Biochem Cell Biol 2002;34:838-854.
40. Lau WW, Ng JK, Lee MM, Chan AS, Wong YH: Interleukin-6 autocrine signaling mediates melatonin mt(1/2) receptor-induced stat3 tyr(705) phosphorylation. J Pineal Res 2012;52:477-489.
41. Hot A, Lenief V, Miossec P: Combination of il-17 and tnfalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis 2012;71:768-776.
42. Fujie H, Niu K, Ohba M, Tomioka Y, Kitazawa H, Nagashima K, Ohrui T, Numasaki M: A distinct regulatory role of th17 cytokines il-17a and il-17f in chemokine secretion from lung microvascular endothelial cells. Inflammation 2012;35:1119-1131.
43. Pickens SR, Volin MV, Mandelin AM 2nd, Kolls JK, Pope RM, Shahrara S: Il-17 contributes to angiogenesis in rheumatoid arthritis. J Immunol 2010;184:3233-3241.
44. Mantovani A, Cassatella MA, Costantini C, Jaillon S: Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011;11:519-531.
45. Kolaczkowska E, Kubes P: Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159-175.
46. Williams MR, Azcutia V, Newton G, Alcaide P, Luscinskas FW: Emerging mechanisms of neutrophil recruitment across endothelium. Trends Immunol 2011;32:461-469.
47. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE, Linden A: Neutrophil recruitment by human il-17 via c-x-c chemokine release in the airways. J Immunol 1999;162:2347-2352.
48. Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, Dai Z, Fan J, Zhou J: Il-17 induces akt-dependent il-6/jak2/stat3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer 2011;10:150.
49. Sun D, Novotny M, Bulek K, Liu C, Li X, Hamilton T: Treatment with il-17 prolongs the half-life of chemokine cxcl1 mrna via the adaptor traf5 and the splicing-regulatory factor sf2 (asf). Nat Immunol 2011;12:853-860.
50. Stalinska K, Guzdek A, Rokicki M, Koj A: Transcription factors as targets of the anti-inflammatory treatment. A cell culture study with extracts from some mediterranean diet plants. J Physiol Pharmacol 2005;56:157-169.
51. Yuan S, Cao S, Jiang R, Liu R, Bai J, Hou Q: Flll31, a derivative of curcumin, attenuates airway inflammation in a multi-allergen challenged mouse model. Int Immunopharmacol 2014;21:128-136.
52. Sano M, Fukuda K, Kodama H, Takahashi T, Kato T, Hakuno D, Sato T, Manabe T, Tahara S, Ogawa S: Autocrine/paracrine secretion of il-6 family cytokines causes angiotensin ii-induced delayed stat3 activation. Biochem Biophys Res Commun 2000;269:798-802.
53. Yuen JW, Poon LS, Chan AS, Yu FW, Lo RK, Wong YH: Activation of stat3 by specific Galpha subunits and multiple gbetagamma dimers. Int J Biochem Cell Biol 2010;42:1052-1059.
54. Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP: Cxc chemokines in angiogenesis. Cytokine Growth Factor Rev 2005;16:593-609.
55. Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, Hishinuma T, Goto J, Lotze MT, Kolls JK, Sasaki H: Il-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in scid mice through promoting cxcr-2-dependent angiogenesis. J Immunol 2005;175:6177-6189.